Amdocs Limited DOX

57.71 (0.65) (1.11%) as of 25 Sep
Market cap
$6.2B
P/E
13.7×
Growth Flags show if company had growth for consecutive years
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

15.90% 16.08% 15.45% 12.95%
ROA
8.77% 8.87% 8.52% 6.98%
ROIC
11.63% 11.19% 10.68% 9.39%
Return on Tangible Assets
55.31% 67.72% 75.52% 71.01%
Average Days of Receivables
75.35 76.75 74.08 79.20
Free Cash Flow per Share
5.92 6.99 6.47 6.17
Free Cash Flow
645.14 754.89 678.74 638.84
Capital Expenditures
(103.95) (108.84) (114.11) (109.98)
Piotroski F-Score
5.00 5.00 5.00 4.00
Other line items
Cash ROIC
16.34% 18.66% 16.98% 16.33%
Accounts Receivable Turnover
4.62 4.69 4.88 4.73
Accounts Payable Turnover
8.30 8.21 8.33 7.65
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
48.19 47.90 43.68 43.69
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.18) (0.17) (0.20) (0.22)
Research and Development Expense of Revenue
7.52% 7.39% 7.44% 7.38%
Selling, General and Administrative Expense of Revenue
11.17% 10.87% 11.18% 11.57%
Share Based Compensation of Revenue
2.31% 2.24% 2.48% 2.37%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.35 1.54 1.48 1.68
Depreciation/Fixed assets
0.26 0.27 0.28 0.28
Capex/Depreciation
(0.53) (0.54) (0.56) (0.53)
Revenue per Share
41.56 42.43 44.05 44.97
Operating CF per Share
6.87 8.00 7.56 7.24
Capex per Share
(0.95) (1.01) (1.09) (1.06)
Capex to Sales
0.02 0.02 0.02 0.02
Net Profit Margin
12.22% 12.24% 11.58% 9.56%

Fold the line items

Columns are period end dates